At LifeBrite Laboratories, we’re proud to be recognized and awarded Top Genetic Diagnostic Service Company by Healthcare Tech Outlook for our industry-leading diagnostic techniques and premier dedication to patient care.
“We understand that patient care is directly affected by laboratory results,” says LifeBrite Labs CEO, Christian Fletcher. “For that reason, we are committed to providing the most accurate and reliable results within industry-leading turnaround times.”
LifeBrite Labs aims to be the one-stop-shop for national medical testing needs by providing testing services for toxicology, chronic care management, therapeutic drug monitoring, chemistry panels, molecular pathology, and more. A key asset is our pharmacogenomics testing, which we use to assess how a patients’ genotypes will influence their response to various medications. This includes medications used in the treatment of cardiovascular disease, pain, diabetes, cancers, and other medical conditions.
In an effort to help in the midst of the global pandemic, LifeBrite has expanded our respiratory pathogens testing to include COVID-19, offering results in under 24 hours. Further, we have been doing our part to assist in large-scale testing by providing drive-up and mobile COVID-19 testing opportunities. We are also rolling out saliva-based PCR testing and antigen testing for those in need of results quickly. To get in touch with us about your COVID-19 testing needs, please reach out via our contact us page.
“We take pride in serving our clients during these challenging times by delivering an elite service with a very fast turnaround time,” says Fletcher. “Our staff ensures they do their best to deliver consistently good customer experiences when patients engage with us.”